Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 1, 2024Journal of Clinical Oncology

Extended follow-up results beyond 2.5 years from the pivotal NHL-1 EPCORE trial: Subcutaneous epcoritamab monotherapy in patients with relapsed/refractory large B-cell lymphoma (R/R LBCL).

View Full Paper
Ask AI
Bookmark
Share

Authors

YKYasmin KarimiUniversity of MichiganCTCatherine ThiéblemontUniversité Claude Bernard Lyon 1HGHervé GhesquièresUniversité Claude Bernard Lyon 1

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Karimi et al. (2024) studied this question.

synapsesocial.com/papers/68e66b19b6db6435875f65fahttps://doi.org/10.1200/jco.2024.42.16_suppl.7039
View Full Paper
Ask AI
Bookmark
Share